Consuelo Pedrón-Giner

Dr. Consuelo Pedrón-Giner


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
JRJana Ruiz
Jana Ruiz
ECELVIRA CAÑEDO
ELVIRA CAÑEDO
JPJuan José García Peñas
Juan José García Peñas
BABeatriz García Alcolea
Beatriz García Alcolea
BFBegoña Gómez Fernández
Begoña Gómez Fernández
CPConsuelo Pedrón-Giner
Consuelo Pedrón-Giner
Background: The ketogenic diet (KD) is an effective treatment against drug-resistant epilepsy in children. The KD is a diet rich in fats that produces anticonvulsant and neuroprotective effects that reduces seizures and improves the cognitive state. Nevertheless, it can produce side effects that sometimes can be serious. Further, the effect on growth is quite controversial when used for an extended period of time. The aim of this paper was to assess the effectiveness, side effects, and repercussions in the development of children who have been treated with a KD for more than 2 years. Methods: Observational descriptive study of 26 pediatric patients on a KD, with data collection at baseline, at 3, 6, and 12 months, and then once a year. Number of seizures, type of seizures, anti-seizure drugs, anthropometry, side effects, and alterations in laboratory assessment were monitored. Results: In every assessment, about 60%–75% of the patients experienced a reduction in number of seizures of over 90%, and at least 50% experienced side effects, of which digestive issues, alteration in the lipid metabolism, and hypercalciuria were the most common. The KD significantly affected height after 2 years of treatment. Conclusions: The KD is an effective treatment for drug-resistant epilepsy. Its side effects, although common, are very mild; therefore, this constitutes a very safe treatment for children of all ages. More studies are needed to identify and prevent potential causes of growth retardation in children on the KD.

5 March 2013 in Child: Care, Health and Development
Verified
Journal Article
Open access
PDF file
CPConsuelo Pedrón-Giner
Consuelo Pedrón-Giner
CCCaterina Calderon
Caterina Calderon
CMCecilia Martínez-Costa
Cecilia Martínez-Costa
SGS. Borraz Gracia
S. Borraz Gracia
LGL. Gómez‐López
L. Gómez‐López
Background & aims: Caregivers of children with chronic diseases included in a home enteral nutrition (HEN) programme are at risk of experiencing a feeling of burden, high level of anxiety and psychological distress. The aims of this study were: first, to examine the prevalence of symptoms of anxiety–depression in caregivers of children with neurological diseases requiring HEN by gastrostomy tube (GT); second, to compare the characteristics of caregivers with high or low risk of exhibiting symptoms of anxiety–depression; and third, to investigate possible associations to child disease severity and nutrition support mode.Methods: A cross‐sectional observational study was performed in 58 caregivers of children (31 boys, aged 0.3–18 years) with neurological diseases and GT feeding. The characteristics of caregivers with high or low risk of presenting symptoms of anxiety–depression were compared regarding the following variables: socio‐demographic characteristics, the primary caregiver's intrapsychic factors, anthropometric parameters of the child, length of HEN, type of nutrients delivered by GT and infusion regime.Results: All primary caregivers were mothers. Fifty‐three per cent of them showed high risk of exhibiting symptoms of anxiety–depression. Mothers with high or low risk of presenting symptoms of anxiety–depression were comparable in age and family socio‐economic status. They were also similar in terms of age, anthropometric conditions and length of HEN in their children.No differences were found between the two groups of mothers according to the level of the child's motor function impairment, type of nutrients delivered by GT and infusion regime. Higher levels of psychological distress and perception of burden overload were found in mothers with high risk of exhibiting symptoms of anxiety–depression.Conclusions: This study found a high prevalence of symptoms of anxiety–depression, perception of burden overload and psychological distress in caregivers of children with HEN. Thus, greater practical and emotional support is required for these families.

6 February 2013 in European Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
CPConsuelo Pedrón-Giner
Consuelo Pedrón-Giner
VNVíctor Manuel Navas-López
Víctor Manuel Navas-López
AMA B Martínez-Zazo
A B Martínez-Zazo
CMCecilia Martínez-Costa
Cecilia Martínez-Costa
FSF Sánchez-Valverde
F Sánchez-Valverde
BPBegoña Pérez-Moneo
Begoña Pérez-Moneo
Background/Objectives: The home enteral nutrition (HEN) provides nutritional support to children with chronic diseases who are nutritionally compromised and allows them to be discharged more quickly from hospitals. In 2003, a web-based registry (Nutrición Enteral Pediátrica Ambulatoria y Domiciliaria, Pediatric Ambulatory and Home Enteral Nutrition -NEPAD-) was created with the objective of gathering information about pediatric HEN practices in Spain. AIM: The aim of this study was to report the implementation of the NEPAD (Nutrición Enteral Pediátrica Ambulatoria y Domiciliaria, Pediatric Ambulatory and Home Enteral Nutrition) registry of pediatric HEN in Spain and to analyze data evolution trends from 2003 to 2010. Subjects/Methods: The data from the Spanish NEPAD registry were analyzed according to the following variables: demographic data, diagnosis, indication for HEN, nutritional support regime and administration route. Results: Over the study period, 952 patients (1048 episodes) from 20 Spanish hospitals were included in the NEPAD registry. The most frequent indication for HEN was decreased oral intake (64%), and neurological disease was the most prevalent illness. HEN was delivered via a nasogastric tube in 573 episodes (54.7%), by gastrostomy in 375 episodes (35.8%), oral feeding in 77 episodes (7.3%) and by jejunal access in 23 episodes (2.2%). Significant differences in the mode of administration were observed based on the pathology of the child (χ2, P<0.0001). The cyclic feeding was the most widely used technique for the administration of HEN. Most of the patients used a pump and a polymeric formula. Transition to oral feeding was the primary reason for discontinuation of this type of support. Conclusions: Since the NEPAD registry was established in Spain, the number of documented patients has increased more than 25-fold. Many children with chronic illness benefit from HEN, mainly those suffering from neurological diseases.

4 March 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
JRJana Ruiz
Jana Ruiz
ECELVIRA CAÑEDO
ELVIRA CAÑEDO
LGLuis González Gutiérrez-Solana
Luis González Gutiérrez-Solana
BABeatriz García Alcolea
Beatriz García Alcolea
BFBegoña Gómez Fernández
Begoña Gómez Fernández
CPConsuelo Pedrón-Giner
Consuelo Pedrón-Giner
Background: Glucose transporter type 1 deficiency syndrome (GLUT1DS) is caused by mutations in the SLC2A1 gene and produces seizures, neurodevelopmental impairment, and movement disorders. Ketogenic dietary therapies (KDT) are the gold standard treatment. Similar symptoms may appear in SLC2A1 negative patients. The purpose is to evaluate the effectiveness of KDT in children with GLUT1DS suspected SLC2A1 (+) and (-), side effects (SE), and the impact on patients nutritional status. Methods: An observational descriptive study was conducted to describe 18 children (January 2009–August 2020). SLC2A1 analysis, seizures, movement disorder, anti-epileptic drugs (AEDS), anthropometry, SE, and laboratory assessment were monitored baseline and at 3, 6, 12, and 24 months after the onset of KDT. Results: 6/18 were SLC2A1(+) and 13/18 had seizures. In these groups, the age for debut of symptoms was higher. The mean time from debut to KDT onset was higher in SLC2A1(+). The modified Atkins diet (MAD) was used in 12 (5 SLC2A1(+)). Movement disorder improved (4/5), and a reduction in seizures >50% compared to baseline was achieved in more than half of the epileptic children throughout the follow-up. No differences in effectiveness were found according to the type of KDT. Early SE occurred in 33%. Long-term SE occurred in 10, 5, 7, and 5 children throughout the follow-up. The most frequent SE were constipation, hypercalciuria, and hyperlipidaemia. No differences in growth were found according to the SLC2A1 mutation or type of KDT. Conclusions: CKD and MAD were effective for SLC2A1 positive and negative patients in our cohort. SE were frequent, but mild. Permanent monitoring should be made to identify SE and nutritional deficits.

5 June 2017 in Nutrición Hospitalaria
Verified
Journal Article
Open access
PDF file
CPConsuelo Pedrón-Giner
Consuelo Pedrón-Giner
MVMargarita Cuervas-Mons Vendrell
Margarita Cuervas-Mons Vendrell
RMRafael Galera Martínez
Rafael Galera Martínez
LLLilianne Gómez López
Lilianne Gómez López
PMPilar Gomis Muñoz
Pilar Gomis Muñoz
SSSenpe Grupo de Estandarización de la Senpe
Senpe Grupo de Estandarización de la Senpe
Introducción:la nutrición parenteral (NP) en la infancia es un tratamiento cuyas características son muy variables en función de la edad y la patología que presente el paciente.Material y métodos: el grupo de Estandarización y Protocolos de la Sociedad Española de Nutrición Parenteral y Enteral (SENPE) es un grupo interdisciplinar formado por miembros de la SENPE, Sociedad Española de Gastroenterología, Hepatología y Nutrición Pediátrica (SEGHNP) y Sociedad Española de Farmacia Hospitalaria (SEFH) que pretende poner al día este tema. Para ello, se ha realizado una revisión pormenorizada de la literatura buscando las evidencias que nos permiten elaborar una Guía de Práctica Clínica siguiendo los criterios del Oxford Centre for Evidence-Based Medicine.Resultados: este manuscrito expone de forma resumida las recomendaciones en cuanto a indicaciones, vías de acceso, requerimientos, modificaciones en situaciones especiales, componentes de las mezclas, prescripción y estandarización, preparación, administración, monitorización, complicaciones y NP domiciliaria. El documento completo se publica como número monográfico.Conclusiones: esta guía pretende servir de apoyo para la prescripción de la NP pediátrica. Constituye la base para tomar decisiones en el contexto de la evidencia existente. Ninguna guía puede tener en cuenta todas las circunstancias clínicas individuales.

1 November 2021 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Open access
JRJana Ruiz
Jana Ruiz
ECElvira Cañedo-Villarroya
Elvira Cañedo-Villarroya
IPIsabel Pérez-Sebastián
Isabel Pérez-Sebastián
BBBeatriz Bernardino-Cuesta
Beatriz Bernardino-Cuesta
CPConsuelo Pedrón-Giner
Consuelo Pedrón-Giner
Ketogenic dietary therapies (KDT) are high-fat and low-carbohydrate diets that may achieve seizure control and improve cognitive state. We describe our KDT experience in infants (children less than two years of age). We conducted a retrospective, descriptive and observational study of 42 infants treated with KDT between 2000-2018. The types of KDT started were: classic ketogenic diet ratio 3:1 (40), ratio 4:1 (1) and modified ketogenic diet with medium-chain triglycerides (1). Four patients switched to a modified Atkins diet. During follow-up, 79%, 57%, 38% and 17% of infants remained on KDT at 3, 6, 12 and 24 months, respectively. Seizure reduction ≥50% compared to baseline was achieved in 50%, 45%, 38% and 17% at 3, 6, 12 and 24 months, respectively. Seizure control was excellent (reduction >90%) in 33%, 31%, 26% and 12%, and seizure-free infants were 9, 9, 10 and 4, at different follow-up intervals, respectively. Sixty-three percent of infants with West syndrome were responders to KDT. Mean length of KDT was 390 days (16 days-4.9 years). Ineffectiveness was the reason for withdrawal in 50% of patients. Early adverse effects (during first month) occurred in 40% of infants. The most frequent early side effects were asymptomatic hypoglycemia and gastrointestinal disturbances. Late-onset side effects occurred in 55-14% of infants during therapy, and most frequent were hypercalciuria and dyslipidaemia. KDT are useful and effective treatments in infancy. Side effects are frequent but mild and easy to manage.